Epithelioid trophoblastic tumor (ETT) is a gestational trophoblastic disease with about 110 case reports in the literature.
[1] Common locations are: They may rarely develop in [2] Epithelioid trophoblastic tumors (ETTs) are resistant to chemotherapy, but an immunotherapy drug called dostarlimab treats gestational trophoblastic neoplasia.
Stage I disease is treated with hysterectomy, while metastatic disease is treated with surgery and chemotherapy.
[2] Metastasis occur in 25% of cases and 10% die of the disease.
Mitotic count of > 6/10HPF is an unfavorable prognostic factor.